SALA / ROOM LOS PRECURSORES

Jueves 29 de noviembre 14:30 - 16:00 hs

14:30

O1 Male sexual function and satisfaction evaluated by Male Sexual Quotient (MSQ) before and after treatment on a large sample of ED patients

Abdo, CHN; Afif-Abdo, J

Ver resumen

14:40

O2 AGE AT FIRST INTERCOURSE AND COITAL FREQUENCY IN BUENOS AIRES, ARGENTINA.

Bertolino, MV; Casabé, AR; Bechara, AJ

Ver resumen

14:50

O3 DISSATISFACTION WITH THE PDE5 INHIBITORS TREATMENT FOR ERECTILE DYSFUNCTION: THE SALVAGE OF THE NON-RESPONSIVE PATIENTS.

Nogueira Jr, JS; Awad, MC; da Silva, EA; Schiavini, JL; Araújo, AC; Damião, R

Ver resumen

15:00

O4 The Real-Life Safety and Efficacy of Vardenafil (REALISE) study – results from the Latin-American region

Jasperson, J; Da Ros, CT; Gromatzky, C; Salas, M; Amenabar Soto, CA; Iraheta Martí, H; Oquelí Torres, C; Espino Corea, O; Grunhaus, A; Fletcher, E; Grullon, E; Landen, H

Ver resumen

15:10

O5 RELATIONSHIP BETWEEN LUTS AND ERECTILE DYSFUNCTION IN MIDDLE-AGED MEN

Casabé, AR; Bertolino, MV; Dédola, P; Bechara, AJ

Ver resumen

15:20

O6 Association Between Androgen Deprivation Therapy and Deterioration of Glycemic Control and Cardiovascular Risk Factors in Men with Type 2 Diabetes Mellitus

Saad, F; Aksam, Y; Haider, A

Ver resumen

15:30

O65 A randomised, double-blind comparison of vardenafil and sildenafil: preference among men with erectile dysfunction and cardiovascular risk factors

Rubio-Aurioles, E; Porst, H; Eardley, I; Goldstein, I

Ver resumen

15:40

O7 Long acting testosterone undecanoate: results after one year of treatment to hypogonadal men.

Rajmil, O; Sánchez - Curbelo, JR; Garza, E; Montañes, R; Arrus- Soldi, JA

Ver resumen

15:50

O8 PHARMACOTHERAPY IN PREMATURE EJACULATION: AN EVIDENCE-BASED APPROACH

Helien, A; Cenice, F; Rosenfeld, C; Gindin, L

Ver resumen